SCHEMBL9192048

SCHEMBL9192048

CC(=O)c1cnc(N)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
SCN9A Q15858 1/20 0.42
SCN2A Q99250 1/20 0.42
SCN3A Q9NY46 1/20 0.42
SCN10A Q9Y5Y9 1/20 0.42
CPB2 Q96IY4 4/20 0.41
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
MAPKAPK2 P49137 1/20 0.36
MAP4K4 O95819 3/20 0.36
ATR Q13535 1/20 0.35
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10386996 0.82 CYP2D6 (0.43) CYP2D6SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL8061081 0.82 GABRP (0.47) CYP2D6SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL31108808 0.80 PDGFRB (0.48) CYP2D6SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL362230 0.80 PDGFRB (0.48) CYP2D6SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL9193384 0.80 CYP2D6 (0.45) CYP2D6SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL13963743 0.80 CYP2D6 (0.48) CYP2D6SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL2421365 0.80 KMT2A (0.51) ALDH1A1MAPK1MEN1KMT2ARXFP1
SCHEMBL9195960 0.78 CA5A (0.40) ALDH1A1MAPK1MEN1KMT2ARXFP1
SCHEMBL2750787 0.78 KMT2A (0.43) ALDH1A1MAPK1MEN1KMT2ARXFP1
SCHEMBL9446832 0.78 SCN9A (0.40) CYP2D6SLC6A2SLC6A4SLC6A3SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365612-B2 Caspase inhibitors UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-06-14 US disclosed
EP-0299277-B1 Process for the preparation of substituted pyridyl-alkyl ketones BAYER AG (DE) 1995-10-18 EP disclosed
EP-0302227-B1 5-HALO-6-AMINO-NICOTINIC ACID HALIDES, THEIR PREPARATION AND THEIR USE BAYER AG (DE) 1993-01-13 EP disclosed
EP-0244728-B1 USE OF HETEROARYLETHYL AMINES TO STIMULATE ANIMAL GROWTH, HETEROARYLETHYL AMINES AND PROCESS FOR THEIR PREPARATION BAYER AG (DE) 1992-11-11 EP disclosed
US-5149822-A PREPARATION OF 2,3-DICHLORO-5-ACETYLPYRIDINE BAYER AKTIENGESELLSCHAFT (DE) 1992-09-22 US disclosed
US-4990620-A Halogen substituted pyridylalkyl ketones BAYER AKTIENGESELLSCHAFT (DE) 1991-02-05 US disclosed
US-4927938-A Halogen substituted pyridylalkyl ketones BAYER AKTIENGESELLSCHAFT (DE) 1990-05-22 US disclosed
US-4895950-A 5-halogeno-6-amino-nicotinic acid halides BAYER AKTIENGESELLSCHAFT (DE) 1990-01-23 US disclosed
EP-0341478-A2 Method for the preparation of 2,3-dichloro-5-acetyl pyridine BAYER AG (DE) 1989-11-15 EP disclosed
EP-0302227-A2 5-Halo-6-amino-nicotinic acid halides, their preparation and their use BAYER AG (DE) 1989-02-08 EP disclosed
EP-0299277-A2 Process for the preparation of substituted pyridyl-alkyl ketones BAYER AG (DE) 1989-01-18 EP disclosed
EP-0244728-A2 Use of heteroarylethyl amines to stimulate animal growth, heteroarylethyl amines and process for their preparation BAYER AG (DE) 1987-11-11 EP disclosed